Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053648830> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W2053648830 endingPage "580" @default.
- W2053648830 startingPage "576" @default.
- W2053648830 abstract "The recent discovery of vascular endothelial growth factor and its role in the pathogenesis of ocular neovascularization has led to the development of new pharmacological agents that could block its action. This study was carried out to investigate the effect of intravitreal injections of bevacizumab on choroidal neovascularization (CNV) associated with pathological myopia.We retrospectively reviewed the charts of all patients who had CNV secondary to pathological myopia and who had been treated with intravitreally administered bevacizumab between November 2005 and April 2007 at Notre-Dame Hospital in Montréal, Québec. Data on best-corrected visual acuity (BCVA), previous treatments, number of injections, fundus photography, and fluorescein angiography were collected.Ten eyes from 9 patients were followed for a mean period of 9.7 (range 2.5-14) months. At baseline the mean (SD) logMAR BCVA was 0.62 (0.25) (Snellen equivalent 6/24). The mean number of injections per eye was 2.6 (range 1-5). At the end of the study the mean (SD) logMAR BCVA had significantly improved to 0.26 (0.16) (Snellen equivalent 6/10.5; p < 0.001). Vision improved by a mean of 3.9 (range 0-7) lines on the Snellen visual acuity chart. Leakage from the CNV on fluorescein angiography had resolved in 7 of the 10 eyes and was reduced in the 3 other eyes. No drug-related side effects or complications were observed during the follow-up period.Intravitreal injection of bevacizumab appears to be a safe and effective treatment alternative for CNV associated with pathological myopia." @default.
- W2053648830 created "2016-06-24" @default.
- W2053648830 creator A5003402398 @default.
- W2053648830 creator A5051147498 @default.
- W2053648830 date "2008-10-01" @default.
- W2053648830 modified "2023-09-25" @default.
- W2053648830 title "Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia" @default.
- W2053648830 cites W110906275 @default.
- W2053648830 cites W1968609549 @default.
- W2053648830 cites W1978101562 @default.
- W2053648830 cites W1988233478 @default.
- W2053648830 cites W1995708259 @default.
- W2053648830 cites W2001684110 @default.
- W2053648830 cites W2015843817 @default.
- W2053648830 cites W2023874692 @default.
- W2053648830 cites W2030940207 @default.
- W2053648830 cites W2033245558 @default.
- W2053648830 cites W2039446733 @default.
- W2053648830 cites W2051258987 @default.
- W2053648830 cites W2058775052 @default.
- W2053648830 cites W2081273617 @default.
- W2053648830 cites W2085712747 @default.
- W2053648830 cites W2124415048 @default.
- W2053648830 cites W2155905635 @default.
- W2053648830 cites W2157769714 @default.
- W2053648830 cites W233579014 @default.
- W2053648830 cites W2410906612 @default.
- W2053648830 doi "https://doi.org/10.3129/i08-104" @default.
- W2053648830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18982035" @default.
- W2053648830 hasPublicationYear "2008" @default.
- W2053648830 type Work @default.
- W2053648830 sameAs 2053648830 @default.
- W2053648830 citedByCount "18" @default.
- W2053648830 countsByYear W20536488302012 @default.
- W2053648830 countsByYear W20536488302013 @default.
- W2053648830 countsByYear W20536488302014 @default.
- W2053648830 countsByYear W20536488302015 @default.
- W2053648830 countsByYear W20536488302018 @default.
- W2053648830 countsByYear W20536488302021 @default.
- W2053648830 crossrefType "journal-article" @default.
- W2053648830 hasAuthorship W2053648830A5003402398 @default.
- W2053648830 hasAuthorship W2053648830A5051147498 @default.
- W2053648830 hasConcept C118487528 @default.
- W2053648830 hasConcept C126322002 @default.
- W2053648830 hasConcept C141071460 @default.
- W2053648830 hasConcept C207886595 @default.
- W2053648830 hasConcept C2776391266 @default.
- W2053648830 hasConcept C2776474195 @default.
- W2053648830 hasConcept C2776599710 @default.
- W2053648830 hasConcept C2776694085 @default.
- W2053648830 hasConcept C2777802072 @default.
- W2053648830 hasConcept C2778257484 @default.
- W2053648830 hasConcept C2778271429 @default.
- W2053648830 hasConcept C2780248432 @default.
- W2053648830 hasConcept C2780394083 @default.
- W2053648830 hasConcept C2781359195 @default.
- W2053648830 hasConcept C71924100 @default.
- W2053648830 hasConceptScore W2053648830C118487528 @default.
- W2053648830 hasConceptScore W2053648830C126322002 @default.
- W2053648830 hasConceptScore W2053648830C141071460 @default.
- W2053648830 hasConceptScore W2053648830C207886595 @default.
- W2053648830 hasConceptScore W2053648830C2776391266 @default.
- W2053648830 hasConceptScore W2053648830C2776474195 @default.
- W2053648830 hasConceptScore W2053648830C2776599710 @default.
- W2053648830 hasConceptScore W2053648830C2776694085 @default.
- W2053648830 hasConceptScore W2053648830C2777802072 @default.
- W2053648830 hasConceptScore W2053648830C2778257484 @default.
- W2053648830 hasConceptScore W2053648830C2778271429 @default.
- W2053648830 hasConceptScore W2053648830C2780248432 @default.
- W2053648830 hasConceptScore W2053648830C2780394083 @default.
- W2053648830 hasConceptScore W2053648830C2781359195 @default.
- W2053648830 hasConceptScore W2053648830C71924100 @default.
- W2053648830 hasIssue "5" @default.
- W2053648830 hasLocation W20536488301 @default.
- W2053648830 hasLocation W20536488302 @default.
- W2053648830 hasOpenAccess W2053648830 @default.
- W2053648830 hasPrimaryLocation W20536488301 @default.
- W2053648830 hasRelatedWork W1189699649 @default.
- W2053648830 hasRelatedWork W1523731927 @default.
- W2053648830 hasRelatedWork W1971001182 @default.
- W2053648830 hasRelatedWork W2012710655 @default.
- W2053648830 hasRelatedWork W2023523208 @default.
- W2053648830 hasRelatedWork W2042631328 @default.
- W2053648830 hasRelatedWork W2053648830 @default.
- W2053648830 hasRelatedWork W2075198919 @default.
- W2053648830 hasRelatedWork W2080584386 @default.
- W2053648830 hasRelatedWork W2551917965 @default.
- W2053648830 hasVolume "43" @default.
- W2053648830 isParatext "false" @default.
- W2053648830 isRetracted "false" @default.
- W2053648830 magId "2053648830" @default.
- W2053648830 workType "article" @default.